pone.0293404.g003.tif (1.05 MB)
Primary outcomes.
figure
posted on 2024-01-02, 18:22 authored by Mariano García-Campa, Ramiro Flores-Ramírez, Sabrina Rojo-Garza, Edgar Francisco Carrizales-Sepúlveda, Diego Regalado-Ceballos, Raúl Reyes-Araiza, Neri Álvarez-Villalobos, Rene Rodríguez-Gutiérrez, José Ramón Azpiri-Lópeza) MACE b) MACE in STEMI c) MACE at 30-days d) MACE 6 months e) All-cause Mortality in STEMI. *p-value presented in the forests plots indicates the statistical significance of I2 tests.
History
Usage metrics
Categories
Keywords
following electronic databases67 &# 821110 &# 8211xlink "> atorvastatinatorvastatin alone comparedterm secondary preventionpercutaneous coronary interventiondose atorvastatin therapydose atorvastatin coulddifferent atorvastatin doseenrolled adult patients30 days postdose atorvastatin prepatients undergoing pcianalysis nstemi undergoing pcistemi patients reduceddose atorvastatinatorvastatin pre30 daysquantitative analysisintervention muststemi patientspatients presentingwidely recommendedsystematic reviewstill doubtstandard carerated overallprotective effectone monthnstemi benefitlong termcontrol groupconfirmed diagnosiscause mortalitybeneficial effects745 comprised029 ).
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC